文献速递呼吸危重症与机械通气呼吸道感染

COVID-19相关ARDS的纵向呼吸亚表型:三项观察性队列研究结果

Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts.
PubMed 文献 · Lancet Respir Med · 2021-10-13

该研究基于荷兰22个ICU的1007例有创机械通气COVID-19患者,采用纵向潜类别分析和基于组的轨迹建模识别呼吸亚表型,发现基线无一致亚表型,纵向识别出两种亚表型,通气比和机械功率的上升轨迹对28天死亡率有独立预后价值,并在美国两个队列中验证。

要点

  • 基线横断面分析未识别出COVID-19相关ARDS的呼吸亚表型。
  • 纵向分析识别出两种亚表型,亚表型2机械功率、分钟通气量和通气比更高。
  • 通气比和机械功率的上升轨迹是28天死亡率的独立预后因素。

核心结论

  • COVID-19相关ARDS基线无一致呼吸亚表型,患者从相对同质 diverged 为异质群体。
  • 通气比和机械功率的轨迹最具区分度,单独建模这些参数可提供机械通气持续时间和死亡的预后价值。

研究设计与样本

  • PRoVENT-COVID为研究者发起的荷兰全国多中心前瞻性观察性队列研究,纳入22个ICU连续接受有创机械通气的COVID-19患者(≥18岁)作为衍生队列。
  • 美国两个ICU的相似患者作为复制队列1(288例)和复制队列2(326例)。
  • 采用潜类别分析横断面(基线)和纵向(有创通气前4天每8小时数据)识别亚表型,并用基于组的轨迹建模评估个体变量轨迹。

主要发现

  • 衍生队列纳入1007例患者(2020年3月1日至5月15日入住参与ICU)。
  • 横断面潜类别分析未识别任何潜在亚表型;纵向潜类别分析识别出两种不同亚表型。
  • 亚表型2在有创机械通气前4天机械功率、分钟通气量和通气比高于亚表型1,但PaO2/FiO2、pH和呼吸系统顺应性无差异。

临床怎么用

  • 临床可动态监测通气比和机械功率轨迹,上升轨迹提示预后较差。
  • 基线呼吸参数不宜用于区分COVID-19相关ARDS亚表型。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with COVID-19-related acute respiratory distress syndrome (ARDS) have been postulated to present with distinct respiratory subphenotypes. However, most phenotyping schema have been limited by sample size, disregard for temporal dynamics, and insufficient validation. We aimed to identify respiratory subphenotypes of COVID-19-related ARDS using unbiased data-driven approaches. METHODS: PRoVENT-COVID was an investigator-initiated, national, multicentre, prospective, observational cohort study at 22 intensive care units (ICUs) in the Netherlands. Consecutive patients who had received invasive mechanical ventilation for COVID-19 (aged 18 years or older) served as the derivation cohort, and similar patients from two ICUs in the USA served as the replication cohorts. COVID-19 was confirmed by positive RT-PCR. We used latent class analysis to identify subphenotypes using clinically available respiratory data cross-sectionally at baseline, and longitudinally using 8-hourly data from the first 4 days of invasive ventilation. We used group-based trajectory modelling to evaluate trajectories of individual variables and to facilitate potential clinical translation. The PRoVENT-COVID study is registered with ClinicalTrials.gov, NCT04346342. FINDINGS: Between March 1, 2020, and May 15, 2020, 1007 patients were admitted to participating ICUs in the Netherlands, and included in the derivation cohort. Data for 288 patients were included in replication cohort 1 and 326 in replication cohort 2. Cross-sectional latent class analysis did not identify any underlying subphenotypes. Longitudinal latent class analysis identified two distinct subphenotypes. Subphenotype 2 was characterised by higher mechanical power, minute ventilation, and ventilatory ratio over the first 4 days of invasive mechanical ventilation than subphenotype 1, but PaO2/FiO2, pH, and compliance of the respiratory system did not differ between the two subphenotypes. 185 (28%) of 671 patients with subphenotype 1 and 109 (32%) of 336 patients with subphenotype 2 had died at day 28 (p=0·10). However, patients with subphenotype 2 had fewer ventilator-free days at day 28 (median 0, IQR 0-15 vs 5, 0-17; p=0·016) and more frequent venous thrombotic events (109 [32%] of 336 patients vs 176 [26%] of 671 patients; p=0·048) compared with subphenotype 1. Group-based trajectory modelling revealed trajectories of ventilatory ratio and mechanical power with similar dynamics to those observed in latent class analysis-derived trajectory subphenotypes. The two trajectories were: a stable value for ventilatory ratio or mechanical power over the first 4 days of invasive mechanical ventilation (trajectory A) or an upward trajectory (trajectory B). However, upward trajectories were better independent prognosticators for 28-day mortality (OR 1·64, 95% CI 1·17-2·29 for ventilatory ratio; 1·82, 1·24-2·66 for mechanical power). The association between upward ventilatory ratio trajectories (trajectory B) and 28-day mortality was confirmed in the replication cohorts (OR 4·65, 95% CI 1·87-11·6 for ventilatory ratio in replication cohort 1; 1·89, 1·05-3·37 for ventilatory ratio in replication cohort 2). INTERPRETATION: At baseline, COVID-19-related ARDS has no consistent respiratory subphenotype. Patients diverged from a fairly homogenous to a more heterogeneous population, with trajectories of ventilatory ratio and mechanical power being the most discriminatory. Modelling these parameters alone provided prognostic value for duration of mechanical ventilation and mortality. FUNDING: Amsterdam UMC.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Bos LDJ, Sjoding M, Sinha P, et al. Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts. Lancet Respir Med. 2021. PMID: 34653374. doi:10.1016/S2213-2600(21)00365-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。